
Merck in Gender Bias Wrangle
Four class representatives have been added to a class-action gender-discrimination employment suit originally filed last May against Merck & Co. in New Jersey.
Four class representatives have been added to a class-action gender-discrimination employment suit originally filed last May against Merck & Co. in New Jersey.
According to
The additional claims raise the potential value of the case against Merck to $250 million. The law firm that added the four plaintiffs - Sanford Heisler - recently won a case against Novartis that cost the firm $253 million in damages.
Kate Mueting, of the plaintiffs’ legal team, told HREOnline that the suit is “further evidence of the pervasive nature of gender-based hostility throughout Merck’s U.S. salesforce.”
Merck responded with the statement: “We are confident that this case lacks merit, and the company will vigorously defend itself. Merck is fully committed to providing equal employment opportunities for all employees and has a strong anti-discrimination policy…”
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.